改良ALPPS用于小婴儿肝母细胞瘤的分期肝切除
本文报道一例54天龄肝母细胞瘤婴儿,因未来肝剩余量不足,采用改良联合肝脏分隔和门静脉结扎的二步肝切除(ALPPS)完成肿瘤切除。作者称这是首例报道改良ALPPS在小婴儿中临床可行且安全的病例,提示该术式可能扩大小婴儿大肝母细胞瘤的手术治疗选择。
要点
- 肝母细胞瘤需及时完整切除,以保证无瘤生存。
- 现有ALPPS证据多来自成人,儿童文献 scarce。
- 改良ALPPS或可扩大小婴儿大肝母细胞瘤的手术选择。
核心结论
- 改良ALPPS在小婴儿肝母细胞瘤中显示临床可行性与安全性,可能扩大手术选择。
研究设计与样本
- 个案报道:54天龄肝母细胞瘤婴儿,未来肝剩余量不足,行改良ALPPS二步肝切除。
主要发现
- 该小婴儿接受改良ALPPS后完成肿瘤切除,作者称其为首例报道。
临床怎么用
- 对未来肝剩余量不足的小婴儿大肝母细胞瘤,改良ALPPS可作为潜在手术备选。
局限性
- 儿童ALPPS文献 scarce,本文为单例报道,结论需更多病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
: For patients with hepatoblastoma, a timely and complete resection of the tumor is critical to the patient's tumor recurrence-free survival. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), a 2-stage hepatectomy procedure, has revolutionized the surgical management of large hepatic tumors with insufficient future liver remnant (FLR) at presentation. Although existing data support the utility of ALPPS in adults with primary and metastatic hepatobiliary malignancy, the literature in children is scarce. To our knowledge, this is the first report showing clinical applicability and safety of the modified ALPPS procedure in a small infant (54 days old) with hepatoblastoma who presented with insufficient FLR. Our report suggests the modified ALPPS could potentially expand the surgical treatment alternative for small infants with large hepatoblastoma.
引用
- Hong JC, Kim J, Browning M, et al. Modified Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Hepatoblastoma in a Small Infant: How Far Can We Push the Envelope? Ann Surg. 2017. PMID: 28288067. doi:10.1097/SLA.0000000000002217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。